Dr. Meenakshi Pande, MD (she/her) is an Endocrinologist in Florence, SC with over 16 years of experience. What is your opinion of Dr. Meenakshi Pande, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Meenakshi Pande, MD has received over $18,502 which includes payments from the following companies:
$7,760.07 from sanofi-aventis U.S. LLC
$4,779.78 from AstraZeneca Pharmaceuticals LP
$1,042.28 from Medtronic MiniMed, Inc.
$660.10 from LILLY USA, LLC
$644.64 from Merck Sharp & Dohme Corporation
$481.80 from Novo Nordisk Inc
$471.78 from INSULET CORPORATION
$389.77 from AbbVie, Inc.
$309.65 from Janssen Pharmaceuticals, Inc
$239.67 from Medtronic Vascular, Inc.
$223.49 from GlaxoSmithKline, LLC.
$219.93 from Boehringer Ingelheim Pharmaceuticals, Inc.
$210.82 from Becton, Dickinson and Company
$149.88 from Amgen Inc.
$135.86 from Takeda Pharmaceuticals America, Inc.
$123.63 from MannKind Corporation
$84.83 from Abbott Laboratories
$81.22 from Shire North American Group Inc
$64.38 from Pfizer Inc.
$61.59 from Roche Diagnostics Corporation
Payments received by Dr. Meenakshi Pande, MD were from the following categories:
$10,660.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!